| Epilepsy research and treatment | Lifetime | 32 | NL 1 | 99.72 |
| Tuberous Sclerosis Complex Research | Lifetime | 4 | NL 1 | 99.31 |
| Neuroscience and Neuropharmacology Research | Lifetime | 182 | NL 1 | 99.70 |
| Neuroinflammation and Neurodegeneration Mechanisms | Lifetime | 117 | NL 1 | 99.40 |
| Pharmacological Effects and Toxicity Studies | Lifetime | 89 | NL 5 | 99.33 |
| Glioma Diagnosis and Treatment | Lifetime | 263 | NL 10 | 99.10 |
| Genetics and Neurodevelopmental Disorders | Lifetime | 179 | NL 11 | 98.89 |
| Drug Transport and Resistance Mechanisms | Lifetime | 231 | NL 18 | 98.76 |
| MicroRNA in disease regulation | Lifetime | 431 | NL 9 | 98.53 |
| Fetal and Pediatric Neurological Disorders | Lifetime | 228 | NL 8 | 97.74 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 223 | NL 10 | 97.42 |
| Genetic and Kidney Cyst Diseases | Lifetime | 246 | NL 7 | 96.39 |
| RNA regulation and disease | Lifetime | 521 | NL 11 | 95.86 |
| Neurogenesis and neuroplasticity mechanisms | Lifetime | 662 | NL 6 | 96.83 |
| Hedgehog Signaling Pathway Studies | Lifetime | 415 | NL 9 | 94.81 |
| Chromatin Remodeling and Cancer | Lifetime | 421 | NL 12 | 90.76 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 886 | NL 22 | 89.81 |
| Infectious Encephalopathies and Encephalitis | Lifetime | 535 | NL 9 | 87.51 |
| Tuberous Sclerosis Complex Research | 2021-2025 | 1 | NL 1 | 98.81 |
| Neuroscience and Neuropharmacology Research | 2021-2025 | 129 | NL 1 | 96.91 |
| Genetics and Neurodevelopmental Disorders | 2021-2025 | 86 | NL 3 | 96.53 |
| Epilepsy research and treatment | 2021-2025 | 95 | NL 2 | 98.01 |
| Pharmacological Effects and Toxicity Studies | 2021-2025 | 360 | NL 13 | 88.68 |
| Genomics and Rare Diseases | 2021-2025 | 757 | NL 31 | 86.76 |
| RNA regulation and disease | 2021-2025 | 389 | NL 13 | 80.72 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 629 | NL 19 | 81.70 |
| Neurogenetic and Muscular Disorders Research | 2021-2025 | 762 | NL 23 | 80.50 |
| Polyomavirus and related diseases | 2021-2025 | 585 | NL 8 | 78.34 |
| Genetic and Kidney Cyst Diseases | 2021-2025 | 513 | NL 25 | 74.76 |
| Fetal and Pediatric Neurological Disorders | 2021-2025 | 877 | NL 39 | 70.87 |
| Tumors and Oncological Cases | 2021-2025 | 757 | NL 32 | 65.03 |
| Infectious Encephalopathies and Encephalitis | 2021-2025 | 516 | NL 19 | 57.13 |
| Histiocytic Disorders and Treatments | 2021-2025 | 421 | NL 12 | 55.38 |
